Filing Details
- Accession Number:
- 0001209191-19-056488
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-11-13 20:05:17
- Reporting Period:
- 2019-11-12
- Accepted Time:
- 2019-11-13 20:05:17
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 897448 | Amarin Corp Plc | AMRN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1376117 | Lars Ekman | C/O Amarin Pharma, Inc. 440 Us Highway 22 Bridgewater NJ 08807 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2019-11-12 | 38,600 | $14.40 | 38,600 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2019-11-12 | 38,600 | $19.35 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Stock Option (Right to Buy) | Disposition | 2019-11-12 | 38,600 | $0.00 | 38,600 | $14.40 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2022-07-10 | No | 4 | M | Direct |
Footnotes
- The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
- The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- Please see the section titled "Remarks" below for additional information.
- The stock option granted to the Reporting Person is fully vested as of the date hereof.
Billionaire Hedge Funds
